Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Perceptive Life Sciences Fund makes global investments in public and private biotechnology products, including drugs, medical devices and diagnostics, with over 25 years of experience. It invests across a company's life cycle, including growth-stage investments, crossover rounds, leading IPOs and public follow-on financings, and the majority of its investments are in small- to mid-cap publicly traded companies. The investment team uses a fundamental scientific approach to identify opportunities and deploy capital across healthcare to support robust development programs.
Parse Score